Azeliragon dihydrochloride (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression in patients with mild Alzheimers disease (AD)[1]. Azel
Molecular Weight:
605.04
CAS Number:
[1284150-65-7]
Formula:
C32H40Cl3N3O2
Target:
Amyloid-beta
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted